Randomized feasibility trial to assess tolerance and clinical effects of lithium in progressive multiple sclerosis

BACKGROUND: Disability accumulation in progressive multiple sclerosis (MS) results from inflammatory and neurodegenerative mechanisms. In animal models of MS, lithium acts to reduce inflammatory demyelination, and in models of neurodegenerative diseases, lithium also slows neuronal death. Prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinker, John R., Meador, William R., King, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393418/
https://www.ncbi.nlm.nih.gov/pubmed/32760832
http://dx.doi.org/10.1016/j.heliyon.2020.e04528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393418/
https://www.ncbi.nlm.nih.gov/pubmed/32760832
http://dx.doi.org/10.1016/j.heliyon.2020.e04528

Ejemplares similares